Scleroderma Clinical Program
New Scleroderma patients, please contact for an appointment:
Academic & Clinical Affairs Manager
72 E Concord Street, Evans, 5th Floor
Boston, MA 02118
Patients and Physicians (P) 617-358-6171
Patient referrals (F) 617-358-6586
Since its inception, the program has evaluated over 1200 patients with scleroderma from around the world. Our multidisciplinary program is highly integrated with experts in many specialties, especially physicians focused on pulmonary fibrosis, pulmonary hypertension and gastrointestinal complications. Expert, individualized patient care is provided by senior physicians (Drs. Trojanowski, York, Bujor) with extensive experience in the care of scleroderma and its many facets. The multidisciplinary care team has partners in Pulmonary, Cardiology, Dermatology, Gastroenterology, Ob/Gyn, Orthopedics (hand specialist), Nutrition, among others, so that patients can receive all of their care by specialists with expertise in all aspects of scleroderma. Care is coordinated with the patient’s primary physician and with other providers when necessary.
For information on enrolling Clinical Trials, please contact Patricia Godio – firstname.lastname@example.org
The Scleroderma Program has two active trials that are open for enrollment.
- A Randomized, Double-blind, Placebo-controlled, Repeat-dose, Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and
Pharmacokinetics of HZN-825 in Patients with Diffuse Cutaneous
- A Double Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of PRA023 in Subjects with Systemic Sclerosis
Associated with Interstitial Lung Disease (SSc-ILD) PR200-104
For more information, please see the video below with Dr. Michael York on the diagnosis and treatment of scleroderma.